Page2RRS

• 29 Oct 2009 04:14

  28/10/09	Q&A on the withdrawal of the marketing authorisation application for Opaxio (paclitaxel poliglumex)	Human Medicines	Withdrawals of Application
  28/10/09	CHMP revised EPAR on: InvanzINN: ertapenemRev. 10 Clopidogrel WinthropINN: clopidogrelRev. 3	Human Medicines	EPARs
  28/10/09	Q&A on the withdrawal of the marketing authorisation application for Zunrisa (casopitant)	Human Medicines	Withdrawals of Application

  28 October, 2009

  Permalink  |  View Entire Page

Search the Site

Custom Search